Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.

Literature DB >> 28579689

Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.

Jan Hansmann¹, Charles E Ray¹.

Abstract

Entities: Disease

Year: 2017 PMID： 28579689 PMCID： PMC5453774 DOI： 10.1055/s-0037-1602757

Source DB: PubMed Journal: Semin Intervent Radiol ISSN： 0739-9529 Impact factor: 1.513

× No keyword cloud information.

52 in total

1. Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort.

Authors: Xavier Adhoute; Guillaume Penaranda; Jean-Pierre Bronowicki; Jean-Luc Raoul
Journal: J Hepatol Date: 2014-09-04 Impact factor: 25.083

2. Staging for hepatocellular carcinoma: complex and confusing.

Authors: Morris Sherman
Journal: Gastroenterology Date: 2014-04-26 Impact factor: 22.682

Review 3. Surgery and portal hypertension.

Authors: C G Child; J G Turcotte
Journal: Major Probl Clin Surg Date: 1964

Review 4. Histological grading and staging of chronic hepatitis.

Authors: K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal: J Hepatol Date: 1995-06 Impact factor: 25.083

5. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Authors: S Chevret; J C Trinchet; D Mathieu; A A Rached; M Beaugrand; C Chastang
Journal: J Hepatol Date: 1999-07 Impact factor: 25.083

6. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.

Authors: I Levy; M Sherman
Journal: Gut Date: 2002-06 Impact factor: 23.059

7. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.

Authors: Teh-Ia Huo; Han-Chieh Lin; Yi-Hsiang Huang; Jaw-Ching Wu; Jen-Huei Chiang; Pui-Ching Lee; Shou-Dong Lee
Journal: Cancer Date: 2006-07-01 Impact factor: 6.860

Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.

1. Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort.

2. Staging for hepatocellular carcinoma: complex and confusing.

Review 3. Surgery and portal hypertension.

Review 4. Histological grading and staging of chronic hepatitis.

5. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

6. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.

7. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.

8. Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Review 9. Comparison of hepatocellular carcinoma in Eastern versus Western populations.

10. Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.

1. MiR-3150b inhibits hepatocellular carcinoma cell proliferation, migration and invasion by targeting GOLPH3.